Tam says cancelled AstraZeneca update was not related to safety concerns  CBC.caView Full coverage on Google News
Canada's chief public health officer said today the National Advisory Committee on Immunization (NACI) recently postponed a planned update to its AstraZeneca guidance because it wanted to incorporate new data about COVID-19 variants — not because of any developments concerning the product's safety.Canada's chief public health officer said today the National Advisory Committee on Immunization (NACI) recently postponed a planned update to its AstraZeneca guidance because it wanted to incorporate new data about COVID-19 variants — not because of any developments concerning the product's safety.

www.cbc.ca

OTTAWA — Canada's chief public health officer says new information on COVID-19 and variants prompted the National Advisory Committee on Immunization to suddenly cancel its planned announcement on who should get the Oxford-AstraZeneca vaccine. The panel, known as NACI for short, is made up of vaccine experts who volunteer their time to make non-binding advice on how vaccines should be used in Canada. NACI was minutes away Tuesday afternoon from providing an update to its advice that AstraZeneca shouldn't be given to people under the age of 55 but the planned briefing was called off. Dr. Theresa Tam says it had nothing to do with the risk the vaccine may pose from rare blood clots, but the panel felt the new data on the virus and its variants of concern had to be taken into account. It is not known when NACI will now deliver that update, but at least five provinces didn't wait for the panel's advice before lowering the age cutoff for the AstraZeneca vaccine. British Columbia, Alberta, Manitoba and Ontario are all now giving it to people as young as 40 and in Quebec as young as 45. This report by The Canadian Press was first published April 21, 2020. The Canadian PressOTTAWA — Canada's chief public health officer says new information on COVID-19 and variants prompted the National Advisory Committee on Immunization to suddenly cancel its planned announcement on who should get the Oxford-AstraZeneca vaccine. The panel, known as NACI for short, is made up of vaccine experts who volunteer their time to make non-binding advice on how vaccines should be used in Canada. NACI was minutes away Tuesday afternoon from providing an update to its advice that AstraZeneca shouldn't be given to people under the age of 55 but the planned briefing was called off. Dr. Theresa Tam says it had nothing to do with the risk the vaccine may pose from rare blood clots, but the panel felt the new data on the virus and its variants of concern had to be taken into account. It is not known when NACI will now deliver that update, but at least five provinces didn't wait for the panel's advice before lowering the age cutoff for the AstraZeneca vaccine. British Columbia, Alberta, Manitoba and Ontario are all now giving it to people as young as 40 and in Quebec as young as 45. This report by The Canadian Press was first published April 21, 2020. The Canadian Press

AstraZeneca advice from national panel delayed by new data on COVID-19 and variants

Tam noted the country has surpassed the milestone of administering 10-million doses of vaccine, though she admits there's still a long way to go.Tam noted the country has surpassed the milestone of administering 10-million doses of vaccine, though she admits there's still a long way to go.

NACI abruptly cancelled AstraZeneca update after receiving new data, Tam says - 680 NEWS

Canada's chief public health officer says new information on COVID-19 and variants prompted the National Advisory Committee on Immunization to suddenly cancel its planned announcement on who should get the Oxford-AstraZeneca vaccine.Canada's chief public health officer says new information on COVID-19 and variants prompted the National Advisory Committee on Immunization to suddenly cancel its planned announcement on who should get the Oxford-AstraZeneca vaccine.

AstraZeneca advice from national panel delayed by new data on COVID variants - Canada News - Castanet.net

Dr. Theresa Tam said the hold up had nothing to do with the risk the vaccine may pose from rare blood clots

New data delays recommendation on AstraZeneca vaccine for Canadians | National Post

New data delays recommendation on AstraZeneca vaccine for Canadians | National Post

www.theglobeandmail.com

Two of Canada's leading health officials say new recommendations for the use of this COVID-19 vaccine are imminent following a sidelined update.Committee cancelled media briefing earlier this week to review new data, says Canada's top doctor

What's the latest news on the AstraZeneca vaccine in Canada? - PrinceGeorgeMatters.com

Chief Medical Health Officer Dr. Theresa Tam is warning against relaxing COVID-19 measures too quickly, suggesting the second vaccine dose will be key.Chief Medical Health Officer Dr. Theresa Tam is warning against relaxing COVID-19 measures too quickly, suggesting the second vaccine dose will be key.

First-dose COVID-19 vaccinations may not be enough to fully re-open, says Tam

OTTAWA - Canada's chief public health officer says new information on COVID-19 and variants prompted...OTTAWA - Canada's chief public health officer says new information on COVID-19 and variants prompted the National Advisory Committee on Immunization to suddenly cancel its planned announcement on who should get the Oxford-AstraZeneca vaccine.NACI was minutes away Tuesday afternoon from providing an update to its advice that AstraZeneca shouldn't be given to people under the age of 55 but the planned briefing was called off.

National AstraZeneca advice delayed by new data - Winnipeg Free Press

Two of Canada’s leading health officials say new recommendations for the use of the AstraZeneca plc COVID-19 vaccine are imminent following a sidelined update earlier this week.Committee cancelled media briefing earlier this week to review new data, says Canada’s top doctor

‘Pertinent’ data delays new recommendations for AstraZeneca use in Canada - Economy, Law & Politics | Business in Vancouver

Two of Canada’s leading health officials say new recommendations for the use of the AstraZeneca plc COVID-19 vaccine are imminent following a sidelined update earlier this week.Committee cancelled media briefing earlier this week to review new data, says Canada’s top doctor

‘Pertinent’ data delays new recommendations for AstraZeneca use in Canada - Economy, Law & Politics | Business in Vancouver